Community-Acquired Pneumonia

General
Facts and Figures
Classification

Presentation
History
Physical Exam
Labs
Radiology

Diagnosis
Criteria for diagnosis
Differential

Microbiology
General
Specific organisms

Pharmacology
Drug Classes
Mechanism of action
Resistance

Treatment
General
Site of care
Medication
Duration
Assessment of responce
Prevention

References
Literature cited
Complete bibliography

Links
More...






Literature Cited

  1. Auble TE, Yealy DM, Fine MJ, Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia, Infectious Disease Clinics of North America, 1998 Sep, 12(3):741-59.

  2. Baron S, ed., Medical Microbiology, 4th ed., 1998.

  3. Bartlett JG, Breiman RF, Mandell LA, File TM Jr., Community-acquired pneumonia in adults: guidelines for management, The Infectious Diseases Society of America, Clinical Infectious Diseases, 1998 Apr, 26(4):811-38.

  4. Bartlett JG, Mundy LM, Community-acquired pneumonia, The New England Journal of Medicine 1995 Dec 14, 333(24):1618-24.

  5. Campbell GD, Overview of community-acquired pneumonia: prognosis and clinical features, Medical Clinics of North America 1994, 78:1035-1048.

  6. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections, European Respiratory Society, European Respiratory Journal, 1998 Apr, 11(4):986-91.

  7. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld, LA, et al, A prediction rule to identify low-risk patients with community-acquired pneumonia, NEJM, 1997 Jan 23, 336(4):243-50.

  8. Fine JM, Hough LJ, Medsger AR, Li YH, Ricci EM, et al, The hospital decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study, Archives of Internal Medicine, 1997 Jan 13, 157(1):36-44.

  9. Garibaldi RA, Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology and impact, Am Journal of Medicine, 1985; 78:32s-37s.

  10. Gilbert DN, Moellering RC Jr, Sande MA, The Sanford Guide to Antimicrobial Therapy, 28th ed., Antimicrobial Therapy Inc., VA, 1998.

  11. Graber MA, Toth PP, Herting RL Jr., University of Iowa Family Practice Handbook , 3rd ed., Mosby, 1997.

  12. Guerra LG, Ho H, Verghese A, New pathogens in pneumonia, Medical Clinics of North America 1994, 78:967-985.

  13. Karetzky M, Burke AC, Brandstetter RD, The Pneumonias, Springer-Verlag, New York, 1993.

  14. Kauppinen M, Pekka S, Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment, Clinical Infectious Diseases, 1995;21:S244-52.

  15. Mandell LA, Antimicrobial approaches to therapy for pneumonia, Current Opinion in Pulmonary Medicine, 1996 May, 2(3):218-27.

  16. Mandell LA, Antibiotics for pneumonia therapy, Medical Clinics of North America 1994, 78:997-1014.

  17. Mandell LA, Community-acquired pneumonia: etiology, epidemiology, and treatment, Chest 1995, 108:35S-42S.

  18. Marrie TJ, New aspects of old pathogens of pneumonia, Medical Clinics of North America 1994, 78:987-995.

  19. Marrie TJ, Community-acquired pneumonia: epidemiology, etiology, treatment, Infectious Disease Clinics of North America, 1998 Sep, 12(3):723-40.

  20. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA, Medical Microbiology, 3rd ed., Mosby, 1998.

  21. Plouffe JF, McNally C, File TM Jr., Value of noninvasive studies in community-acquired pneumonia, Infectious Disease Clinics of North America, 1998 Sep, 12(3):689-99.

  22. Skerret SJ, Host defenses against respiratory infection, Medical Clinics of North America 1994, 78:941-966.

Home Jeeves! Top of page
© Copyright 1999, All rights reserved. L. España. Rev. 3/99
medschool.ucsd.edu/curricular_resources/MED/CAP/index.html   3/30/99